Share

August 26, 2014; 83 (9) Article

Are confusional arousals pathological?

Maurice M. Ohayon, Mark W. Mahowald, Damien Leger
First published August 25, 2014, DOI: https://doi.org/10.1212/WNL.0000000000000727
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
445

Share

Article Information

vol. 83 no. 9 834-841
DOI: 
https://doi.org/10.1212/WNL.0000000000000727
PubMed: 
25156346
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received May 25, 2012
  • Accepted in final form May 22, 2014
  • First Published August 25, 2014.
Copyright & Usage: 
© 2014 American Academy of Neurology

Author Disclosures

    1. Maurice M. Ohayon, MD, DSc, PhD,
    2. Mark W. Mahowald, MD, PhD and
    3. Damien Leger, MD, PhD
  1. Maurice M. Ohayon, MD, DSc, PhD,
    2. Scientific Advisory Boards:

    1. Jazz Pharmaceuticals

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Sleep, editorial advisory board, 1998-2013; (2) Sleep, associate editor, 2013-present; (3) Sleep Medicine, editorial advisory board, 2000-present; (4) Journal of Psychiatry Research, Assistant Editor, 2006-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. Society for Women�s Health Research (SWHR), panelist, Sleep Round Table, October 2013.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1) Research gift from Jazz Pharmaceuticals

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Mark W. Mahowald, MD, PhD and
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Damien Leger, MD, PhD
    4. Scientific Advisory Boards:

    1. (1) Sanofi-Aventis, (2) Lundbeck, (3) Actelion, (4) GSK, (5) Lilly, (6) Pfizer, (7) Merck, (8) Philips Respironics, (9) Vanda, (10) Bioprojets, (11) APL, (12) Zyken, (13) Air Liquide international

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Journal of Sleep Research, (2) Medecine du Sommeil (3) Sleep Medecine Review

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Sanofi-Aventis, (2) Lundbeck, (3) Actelion, (4) GSK, (5) Lilly, (6) Pfizer, (7) Merck, (8) Philips Respironics, (9) Vanda, (10) Bioprojets, (11) APL, (12) Zyken, (13) Air Liquide International

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Sanofi-Aventis, (2) Lundbeck, (3) Actelion, (4) GSK, (5) Lilly, (6) Pfizer, (7) Merck, (8) Philips Respironics, (9) Vanda, (10) Bioprojets, (11) APL, (12) Zyken, (13) Air Liquide International

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Division of Public Mental Health and Population Sciences, Stanford Sleep Epidemiology Research Center (M.M.O.), School of Medicine, Stanford University, CA; Minnesota Regional Sleep Disorders Center (M.W.M.), Department of Neurology, Hennepin County Medical Center, The University of Minnesota Medical School, Minneapolis; Université Paris Descartes (D.L.), APHP, Hôtel-Dieu de Paris, Centre du Sommeil et de la Vigilance, France.
  1. Correspondence to Dr. Ohayon: mohayon{at}stanford.edu
View Full Text

Article usage

Article usage: August 2014 to August 2021

AbstractFullPdfSource
Aug 201446633974Highwire
Sep 201424192851Highwire
Oct 2014713839Highwire
Nov 201436623Highwire
Dec 201425135Highwire
Jan 2015244210Highwire
Feb 201521913Highwire
Mar 2015265210Highwire
Apr 201512510Highwire
May 201511011Highwire
Jun 201512221Highwire
Jul 201516811Highwire
Aug 201516636Highwire
Sep 201517712Highwire
Oct 201513150Highwire
Nov 201512343Highwire
Dec 20159500Highwire
Jan 201614111Highwire
Feb 20169622Highwire
Mar 201611030Highwire
Apr 201612112Highwire
May 201612402Highwire
Jun 201616600Highwire
Jul 201611733Highwire
Aug 201615600Highwire
Sep 201610500Highwire
Oct 20168701Highwire
Nov 201610500Highwire
Dec 20166801Highwire
Jan 201711312Highwire
Feb 201710112Highwire
Mar 20177501Highwire
Apr 20177201Highwire
May 20178300Highwire
Jun 20176712Highwire
Jul 20177500Highwire
Aug 201711102Highwire
Sep 201721700Highwire
Oct 201722622Highwire
Nov 20177220Highwire
Dec 201710723Highwire
Jan 20189225Highwire
Feb 20189230Highwire
Mar 201811332Highwire
Apr 201812012Highwire
May 201819233Highwire
Jun 201816813Highwire
Jul 201819123Highwire
Aug 20189122Highwire
Sep 20189934Highwire
Oct 20189221Highwire
Nov 201812212Highwire
Dec 201817513Highwire
Jan 201910911Highwire
Feb 201911002Highwire
Mar 201910533Highwire
Apr 20199635Highwire
May 20199014Highwire
Jun 201910532Highwire
Jul 201911061Highwire
Aug 201913275Highwire
Sep 2019161710Highwire
Oct 2019171615Highwire
Nov 2019139811Highwire
Dec 2019167513Highwire
Jan 202015767Highwire
Feb 2020153513Highwire
Mar 2020111317Highwire
Apr 2020135018Highwire
May 2020158111Highwire
Jun 20204645Highwire
Jul 202086310Highwire
Aug 20206031Highwire
Sep 20205000Highwire
Oct 202010412Highwire
Nov 202013436Highwire
Dec 202011210Highwire
Jan 202110703Highwire
Feb 20217711Highwire
Mar 202110212Highwire
Apr 20218032Highwire
May 202111410Highwire
Jun 20215741Highwire
Jul 20218672Highwire
Aug 202110376Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me